Preservation of ATP, ultrastructure, and ventricular function after aortic cross-clamping and reperfusion. Clinical use of blood potassium cardioplegia.
D000255:Adenosine Triphosphate / Q000378:metabolism*; D001011:Aorta / Q000601:surgery*; D001769:Blood; D003250:Constriction; D004562:Electrocardiography; D006324:Heart Arrest, Induced / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007036:Hypothermia, Induced; D008929:Mitochondria, Heart / Q000648:ultrastructure; D008991:Monitoring, Physiologic; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism* / Q000648:ultrastructure; D011184:Postoperative Period; D011188:Potassium / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors
D000255:Adenosine Triphosphate; D011188:Potassium